Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3510171011 | Tumor necrosis factor alpha inhibitor (disposition) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3510172016 | Tumor necrosis factor alpha inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3510173014 | Tumour necrosis factor alpha inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tumor necrosis factor alpha inhibitor (disposition) | est un(e) (attribut) | Immunomodulator (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Certolizumab pegol (substance) | Has disposition (attribute) | True | Tumor necrosis factor alpha inhibitor (disposition) | Inferred relationship | Some | |
| Golimumab | Has disposition (attribute) | True | Tumor necrosis factor alpha inhibitor (disposition) | Inferred relationship | Some | |
| Infliximab (substance) | Has disposition (attribute) | True | Tumor necrosis factor alpha inhibitor (disposition) | Inferred relationship | Some | |
| Etanercept (substance) | Has disposition (attribute) | True | Tumor necrosis factor alpha inhibitor (disposition) | Inferred relationship | Some | |
| adalimumab | Has disposition (attribute) | True | Tumor necrosis factor alpha inhibitor (disposition) | Inferred relationship | Some | |
| agent anti-tumor necrosis factor alpha | Has disposition (attribute) | True | Tumor necrosis factor alpha inhibitor (disposition) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR